Evaluating the Anti-Migratory Effect of Fucoxanthin in Human Cisplatin-Resistant Ovarian Cancer Cells.

Background & Objective: Ovarian cancer ranks among the most prevalent gynecologic cancers in women with the majority of patients experiencing a recurrent type and developing treatment resistance. Resistance to chemotherapy drugs has been observed to trigger epithelial-mesenchymal transition (EMT), w...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Advances in Medical & Biomedical Research Vol. 32; no. 151; pp. 135 - 144
Autores principales: Sani, Fatemeh Valinezhad, Ghofrani, Shiva, Kamalian, Safa, Gharaee, Melika Ehtesham, Mosaffa, Fatemeh
Formato: pictorial research tables/charts Journal Article
Publicado: Zanjan University of Medical Sciences & Health Services Mar/Apr2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179303473&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 179303473
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        26766264
        N5MJ
      jtl: Journal of Advances in Medical & Biomedical Research
      issn: 26766264
      maglogo: N
    pubinfo:
      dt: Mar/Apr2024
      vid: 32
      iid: 151
      pid: 65276
      pub: Zanjan University of Medical Sciences & Health Services
    artinfo:
      ui:
        179303473
        179303473
        179303473
        10.30699/jambr.32.151.135
        179303473
      ppf: 135
      ppct: 9
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Evaluating the Anti-Migratory Effect of Fucoxanthin in Human Cisplatin-Resistant Ovarian Cancer Cells.
      aug:
        au:
          Sani, Fatemeh Valinezhad
          Ghofrani, Shiva
          Kamalian, Safa
          Gharaee, Melika Ehtesham
          Mosaffa, Fatemeh
        affil: Department of Laboratory Sciences, School of Paramedical and Rehabilitation Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
      sug:
        subj:
          Xanthophylls Therapeutic Use
          Cisplatin Therapeutic Use
          Antineoplastic Agents Therapeutic Use
          Drug Resistance, Neoplasm Evaluation
          Ovarian Neoplasms Drug Therapy
          Cell Line, Tumor
          Drug Efficacy
          Human
          Funding Source
          Female
          Adult
          Epithelial-Mesenchymal Transition
          Chemotherapy, Cancer
          Cell Migration Assays
          Wound Healing
          Reverse Transcriptase Polymerase Chain Reaction
          RNA, Messenger
          Cell Viability
          Spectrophotometry
          Descriptive Statistics
          One-Way Analysis of Variance
          Gene Expression
          Adult: 19-44 years
          Female
      ab: Background & Objective: Ovarian cancer ranks among the most prevalent gynecologic cancers in women with the majority of patients experiencing a recurrent type and developing treatment resistance. Resistance to chemotherapy drugs has been observed to trigger epithelial-mesenchymal transition (EMT), which leads to the acquisition of metastatic properties. Thus, targeting the molecular mechanism of EMT may lead to novel interventions against metastatic disease. In this research, the suppressive impacts of fucoxanthin, as a natural compound, were examined on cell migration and expression of key EMT-related markers in ovarian cancer cells which were sensitive and resistant to cisplatin. Materials & Methods: To determine the non-toxic concentrations of fucoxanthin for migration assay, the MTT assay was conducted. To assess the anti-migratory capacity of fucoxanthin in ovarian cancer cells which were sensitive and resistant to cisplatin, a wound-healing migration test was done in the presence of non-toxic concentrations of fucoxanthin. RT-qPCR was utilized to examine the impact of fucoxanthin on the mRNA expression of E-cadherin, vimentin and α- SMA (as EMT-related markers) in ovarian cancer cells. Results: Fucoxanthin at concentrations of (1 and 2.5 μM) downregulated the expression of α–SMA in cisplatin-resistant ovarian cancer cells and inhibited migration in ovarian cancer cell lines. Conclusion: Fucoxanthin exhibited remarkable efficacy in inhibiting migration in in ovarian cancer cells which were sensitive and resistant to cisplatin. However, more research is required to ascertain the clinical advantages linked to utilizing fucoxanthin in the treatment of cisplatin-resistant ovarian cancers.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N